Cargando…
Acute myeloid leukemia development soon after anti-CD19 chimeric antigen receptor T-cell infusion in a patient with refractory diffuse large B-cell lymphoma and pre-existing clonal hematopoiesis
Autores principales: | Falini, Lorenza, Venanzi, Alessandra, Tini, Valentina, Innocente, Alessandra, Ballanti, Stelvio, Saldi, Simonetta, Sivolella, Silvio, Pierini, Antonio, Aristei, Cynthia, Tiacci, Enrico, Perriello, Vincenzo Maria, Falini, Brunangelo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827176/ https://www.ncbi.nlm.nih.gov/pubmed/35899391 http://dx.doi.org/10.3324/haematol.2022.281351 |
Ejemplares similares
-
Case Report: Subtotal Lymphoid and Total Marrow Irradiation as Bridge Therapy to CD19-Directed CAR T Cells in a Chemorefractory DLBCL With Leukemic Involvement
por: Saldi, Simonetta, et al.
Publicado: (2022) -
Polatuzumab‐bendamustine‐rituximab as bridge to CD19‐directed CAR T cells in mantle cell lymphoma refractory to ibrutinib and venetoclax
por: Perriello, Vincenzo Maria, et al.
Publicado: (2023) -
Safety and efficacy of the BRAF inhibitor dabrafenib in relapsed or refractory hairy cell leukemia: a pilot phase-2 clinical trial
por: Tiacci, Enrico, et al.
Publicado: (2021) -
Genomics of Hairy Cell Leukemia
por: Tiacci, Enrico, et al.
Publicado: (2017) -
A Curious Novel Combination of Nucleophosmin (NPM1) Gene Mutations Leading to Aberrant Cytoplasmic Dislocation of NPM1 in Acute Myeloid Leukemia (AML)
por: Venanzi, Alessandra, et al.
Publicado: (2021)